SERNYSEPharmaceutical PreparationsFiscal year ends December 31
Serina Therapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$1.65−0.07 (-4.07%)
Close on Oct 19, 2026
- Market cap
- $27.04M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Serina Therapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Oct 5, 2026 | Oct 9, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 9, 2026 | Sep 9, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 21, 2026 | Aug 27, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 13, 2026 | Aug 13, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 13, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 19, 2026 | Jul 23, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 22, 2026 | Jul 22, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 17, 2026 | Jun 24, 2026 | SEC EDGAR |
| Current report | 8-K | May 14, 2026 | May 14, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 14, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Apr 27, 2026 | Apr 27, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 15, 2026 | Apr 21, 2026 | SEC EDGAR |
| Annual report, amended | 10-K/A | Dec 31, 2025 | Mar 27, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 25, 2026 | Mar 25, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 25, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 17, 2026 | Mar 23, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 27, 2026 | Jan 28, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 9, 2026 | Jan 15, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 10, 2025 | Dec 10, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 13, 2025 | Nov 13, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 13, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 7, 2025 | Nov 12, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 3, 2025 | Nov 3, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 6, 2025 | Oct 6, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Sep 26, 2025 | Sep 26, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 9, 2025 | Sep 15, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 9, 2025 | Sep 9, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 25, 2025 | Aug 25, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 18, 2025 | Aug 22, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 11, 2025 | Aug 11, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 11, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 29, 2025 | Jul 29, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 1, 2025 | Jul 1, 2025 | SEC EDGAR |
| Current report | 8-K | May 22, 2025 | May 22, 2025 | SEC EDGAR |
| Current report | 8-K | May 8, 2025 | May 8, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 8, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 25, 2025 | Apr 29, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 15, 2025 | Apr 15, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 8, 2025 | Apr 14, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 7, 2025 | Apr 7, 2025 | SEC EDGAR |